Synopsis of recent research by authors named "Anping Su"
* His studies include retrospective cohort analyses of intermediate-risk papillary thyroid carcinoma, evaluations of post-marketing safety data for the drug teprotumumab used in thyroid eye disease, and investigation into novel therapeutic pathways for aggressive thyroid cancers like anaplastic thyroid carcinoma.
* Additionally, Su's work encompasses reviews of pharmacological treatments for Tourette's syndrome and assessments of telemedicine approaches in thyroid surgery clinical care, showcasing a commitment to integrating clinical practice with modern healthcare technologies.*